Motoi Kobayashi
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes 2
- Cancer Research top 10%
-
- Ferroptosis and cancer prognosis 3
-
- Inflammasome and immune disorders 7
- Ion channel regulation and function 2
-
- Cardiac electrophysiology and arrhythmias 2
-
- Trace Elements in Health 2
-
- Iron Metabolism and Disorders 2
-
- Pregnancy and preeclampsia studies 1
- Co-authors
- Tomohiro SuharaYuichi BabaJason K. HigaTakashi MatsuiTadayoshi KarasawaHiroaki KimuraMasafumi TakahashiBriana K. Shimada
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Motoi Kobayashi
21 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Nephrology 188
- Cancer Research 213
- Pulmonary and Respiratory Medicine 359
- Molecular Biology 525
- Cardiology and Cardiovascular Medicine 157
Countries citing papers authored by Motoi Kobayashi
This map shows the geographic impact of Motoi Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motoi Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motoi Kobayashi more than expected).
Fields of papers citing papers by Motoi Kobayashi
This network shows the impact of papers produced by Motoi Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motoi Kobayashi. The network helps show where Motoi Kobayashi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Motoi Kobayashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 9 | |
| 2 | 2021 | 4 | |
| 3 | 2019 | 1 | |
| 4 | 2018 | 18 | |
| 5 | 2018 | 125 | |
| 6 | 2017 | 35 | |
| 7 | Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytesbreakdown → | 2017 | 288 |
| 8 | 2016 | 57 | |
| 9 | 2016 | 17 | |
| 10 | 2015 | 26 | |
| 11 | 2015 | 87 | |
| 12 | 2015 | 59 | |
| 13 | 2014 | 50 | |
| 14 | 2013 | 7 | |
| 15 | 2011 | 12 | |
| 16 | 2011 | 11 | |
| 17 | 2008 | 43 | |
| 18 | 2008 | 140 | |
| 19 | 1994 | 14 | |
| 20 | 1986 | 17 |
About Motoi Kobayashi
Motoi Kobayashi is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pharmacy, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (7 papers), Ferroptosis and cancer prognosis (3 papers), Trace Elements in Health (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Ion channel regulation and function (2 papers), Iron Metabolism and Disorders (2 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Pregnancy and preeclampsia studies (1 paper). The work is most often cited by research in Nephrology (188 citations), Cancer Research (213 citations) and Pulmonary and Respiratory Medicine (359 citations). Motoi Kobayashi has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Tomohiro Suhara, Yuichi Baba, Jason K. Higa, Takashi Matsui, Tadayoshi Karasawa, Hiroaki Kimura, Masafumi Takahashi, Briana K. Shimada, Fumitake Usui and Hiroaki Kitaoka. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.